OM:BONEXBiotechs
Assessing Bonesupport Holding (OM:BONEX) Valuation After Updated 2025–2026 Earnings Guidance
Bonesupport Holding (OM:BONEX) has drawn fresh attention after issuing earnings guidance that points to 313 MSEK in Q4 2025 net sales and sales growth above 35% for full year 2026 at constant exchange rates.
See our latest analysis for Bonesupport Holding.
Despite the new guidance, Bonesupport Holding’s recent trading has been mixed, with a 7.23% 1 month share price return and a 9.21% year to date share price return contrasting with a 42.72% 1 year total shareholder return decline. The 3 and...